• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度和尼泊尔新冠疫情的数学建模及最优控制与敏感性分析

Mathematical modeling of COVID-19 in India and Nepal with optimal control and sensitivity analysis.

作者信息

Bandekar Shraddha Ramdas, Ghosh Mini

机构信息

Division of Mathematics, School of Advanced Sciences, Vellore Institute of Technology, Chennai, India.

出版信息

Eur Phys J Plus. 2021;136(10):1058. doi: 10.1140/epjp/s13360-021-02046-y. Epub 2021 Oct 21.

DOI:10.1140/epjp/s13360-021-02046-y
PMID:34697579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8528663/
Abstract

The pandemic started in the late 2019 and is still waving in claiming millions of lives with virus being mutated to deadlier form. This pandemic has caught attention toward interventions like improved detection of the infected, better quarantine facilities and adequate medical facilities in terms of hospital beds and other medical aid. In this study, we developed a 7-compartment epidemiological model, with inclusion of identified and unidentified infected population along with media factor associated with the aware identified infected population. This is included by using Holling function in the nonlinear incidence, that is responsible for reduction in infection rate via identified infected. The model is fitted to the observed active COVID-19 cases data, collected for a period of 11 months between July 2020 to May 2021 of Nepal and India, and the infection rate as well as the basic reproduction number is obtained for the first wave and second wave of the pandemic in both countries. A comparative analysis on the effect of different parameters on the disease prevalence for both the countries is presented in this work. Sensitivity analysis, time series behavior and optimal control analysis with control parameters equating with reduced infection rate, enhanced detection rate, improved quarantine and hospitalization rate are presented in detail. By means of PRCC, sensitivity analysis is performed and the key parameters influencing the disease prevalence are identified. A detailed study on impact of several parameters in the COVID-19 prevalence, thereby suggesting the interventions to be implemented is discussed in the work. Predictions till June 30, 2021, are obtained using the second wave data for both the countries, and a declining trend is observed for both the countries for the next 30 to 40 days. The estimated values of the infection rates and the hospitalization rates obtained are higher for India compared to Nepal. An optimal control analysis for both the countries is described in detail providing the difference in infectives and recoveries with and without any controls or interventions. The study suggests that improved treatment facilities, testing drives and other non-pharmaceutical interventions would bring down the infected cases to a major extent.

摘要

这场大流行始于2019年末,至今仍在肆虐,随着病毒变异为更致命的形式,已夺去数百万人的生命。这场大流行引发了人们对一些干预措施的关注,比如改进对感染者的检测、改善隔离设施以及在病床和其他医疗援助方面提供充足的医疗设施。在本研究中,我们开发了一个七房室流行病学模型,纳入了已识别和未识别的感染人群,以及与已识别且知晓的感染人群相关的媒体因素。这是通过在非线性发病率中使用Holling函数实现的,该函数负责通过已识别的感染者降低感染率。该模型拟合了2020年7月至2021年5月期间为尼泊尔和印度收集的为期11个月的观察到的活跃新冠肺炎病例数据,并得出了两国大流行第一波和第二波的感染率以及基本再生数。本文对不同参数对两国疾病流行率的影响进行了比较分析。详细介绍了敏感性分析、时间序列行为以及控制参数等同于降低感染率、提高检测率、改善隔离和住院率的最优控制分析。通过PRCC进行敏感性分析,并确定了影响疾病流行率的关键参数。本文详细讨论了几个参数对新冠肺炎流行率的影响,从而提出了有待实施的干预措施。利用两国的第二波数据获得了截至2021年6月

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/c75d3b341f77/13360_2021_2046_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/5614cb4971a2/13360_2021_2046_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/0d9e4713aaa0/13360_2021_2046_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/af6179e72c94/13360_2021_2046_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/048bd472feea/13360_2021_2046_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/8735938bc470/13360_2021_2046_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/7d4da53829c7/13360_2021_2046_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/2895acbb5c8b/13360_2021_2046_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/0d9e854b2b84/13360_2021_2046_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/abe42ea66071/13360_2021_2046_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/0b89c60fd5e0/13360_2021_2046_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/0ff591e25a35/13360_2021_2046_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/3b9b9decea35/13360_2021_2046_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/fe74a245f487/13360_2021_2046_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/07bb28ed7d83/13360_2021_2046_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/d923ec63b9d3/13360_2021_2046_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/c75d3b341f77/13360_2021_2046_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/5614cb4971a2/13360_2021_2046_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/0d9e4713aaa0/13360_2021_2046_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/af6179e72c94/13360_2021_2046_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/048bd472feea/13360_2021_2046_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/8735938bc470/13360_2021_2046_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/7d4da53829c7/13360_2021_2046_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/2895acbb5c8b/13360_2021_2046_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/0d9e854b2b84/13360_2021_2046_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/abe42ea66071/13360_2021_2046_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/0b89c60fd5e0/13360_2021_2046_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/0ff591e25a35/13360_2021_2046_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/3b9b9decea35/13360_2021_2046_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/fe74a245f487/13360_2021_2046_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/07bb28ed7d83/13360_2021_2046_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/d923ec63b9d3/13360_2021_2046_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e05f/8528663/c75d3b341f77/13360_2021_2046_Fig16_HTML.jpg

相似文献

1
Mathematical modeling of COVID-19 in India and Nepal with optimal control and sensitivity analysis.印度和尼泊尔新冠疫情的数学建模及最优控制与敏感性分析
Eur Phys J Plus. 2021;136(10):1058. doi: 10.1140/epjp/s13360-021-02046-y. Epub 2021 Oct 21.
2
Modeling the impact of non-pharmaceutical interventions on the dynamics of novel coronavirus with optimal control analysis with a case study.通过案例研究,运用最优控制分析对非药物干预措施对新型冠状病毒动态的影响进行建模。
Chaos Solitons Fractals. 2020 Oct;139:110075. doi: 10.1016/j.chaos.2020.110075. Epub 2020 Jul 3.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
5
A co-infection model on TB - COVID-19 with optimal control and sensitivity analysis.一种具有最优控制和敏感性分析的结核病-新冠肺炎合并感染模型。
Math Comput Simul. 2022 Oct;200:1-31. doi: 10.1016/j.matcom.2022.04.001. Epub 2022 Apr 16.
6
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.旅行相关的控制措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717.
7
The impact of travelling on the COVID-19 infection cases in Germany.旅行对德国 COVID-19 感染病例的影响。
BMC Infect Dis. 2022 May 12;22(1):455. doi: 10.1186/s12879-022-07396-1.
8
Mathematical modeling and stability analysis of the COVID-19 with quarantine and isolation.新冠疫情防控措施下的数学建模与稳定性分析
Results Phys. 2022 Mar;34:105284. doi: 10.1016/j.rinp.2022.105284. Epub 2022 Feb 8.
9
Mathematical modeling of COVID-19 in India and its states with optimal control.印度及其各邦新冠疫情的数学建模与最优控制
Model Earth Syst Environ. 2022;8(2):2019-2034. doi: 10.1007/s40808-021-01202-8. Epub 2021 Jun 10.
10
Non Pharmaceutical Interventions for Optimal Control of COVID-19.非药物干预措施以实现 COVID-19 的最佳控制。
Comput Methods Programs Biomed. 2020 Nov;196:105642. doi: 10.1016/j.cmpb.2020.105642. Epub 2020 Jul 7.

引用本文的文献

1
Optimal time-dependent SUC model for COVID-19 pandemic in India.印度 COVID-19 大流行的最优时变 SUC 模型。
BMC Infect Dis. 2024 Sep 27;24(1):1031. doi: 10.1186/s12879-024-09961-2.

本文引用的文献

1
Predicting the Spread of COVID-19 Using Model Augmented to Incorporate Quarantine and Testing.使用纳入隔离和检测的模型增强方法预测新冠病毒病的传播
Trans Indian Natl Acad Eng. 2020;5(2):141-148. doi: 10.1007/s41403-020-00151-5. Epub 2020 Jul 24.
2
A Time-Dependent SIR Model for COVID-19 With Undetectable Infected Persons.一种针对新冠病毒病(COVID-19)且存在未被检测出感染者的时间依赖性易感-感染-康复(SIR)模型
IEEE Trans Netw Sci Eng. 2020 Sep 18;7(4):3279-3294. doi: 10.1109/TNSE.2020.3024723. eCollection 2020 Oct 1.
3
Mathematical modeling of COVID-19 in India and its states with optimal control.
印度及其各邦新冠疫情的数学建模与最优控制
Model Earth Syst Environ. 2022;8(2):2019-2034. doi: 10.1007/s40808-021-01202-8. Epub 2021 Jun 10.
4
The second and third waves in India: when will the pandemic be culminated?印度的第二波和第三波疫情:疫情何时会达到顶峰?
Eur Phys J Plus. 2021;136(5):596. doi: 10.1140/epjp/s13360-021-01586-7. Epub 2021 May 28.
5
A mathematical model for the impacts of face mask, hospitalization and quarantine on the dynamics of COVID-19 in India: deterministic vs. stochastic.用于评估口罩、住院和隔离对印度 COVID-19 动态影响的数学模型:确定性与随机。
Math Biosci Eng. 2020 Nov 26;18(1):182-213. doi: 10.3934/mbe.2021010.
6
A simple model for fitting mild, severe, and known cases during an epidemic with an application to the current SARS-CoV-2 pandemic.一种用于拟合疫情期间轻症、重症和已知病例的简单模型及其在当前新冠疫情中的应用。
Infect Dis Model. 2021;6:313-323. doi: 10.1016/j.idm.2021.01.002. Epub 2021 Jan 15.
7
COVID-19; current situation and recommended interventions.新型冠状病毒肺炎(COVID-19);现状与推荐干预措施。
Int J Clin Pract. 2021 May;75(5):e13886. doi: 10.1111/ijcp.13886. Epub 2021 Jan 14.
8
Predictive model with analysis of the initial spread of COVID-19 in India.预测模型分析印度 COVID-19 的初始传播情况。
Int J Med Inform. 2020 Nov;143:104262. doi: 10.1016/j.ijmedinf.2020.104262. Epub 2020 Aug 25.
9
Can India develop herd immunity against COVID-19?印度能发展出针对新冠病毒的群体免疫吗?
Eur Phys J Plus. 2020;135(6):526. doi: 10.1140/epjp/s13360-020-00531-4. Epub 2020 Jun 26.
10
Estimating the parameters of susceptible-infected-recovered model of COVID-19 cases in India during lockdown periods.估算印度封锁期间新冠疫情易感-感染-康复模型的参数。
Chaos Solitons Fractals. 2020 Nov;140:110154. doi: 10.1016/j.chaos.2020.110154. Epub 2020 Jul 29.